摘要
目的:探讨微小RNA-126(miR-126)增强胃癌细胞放射敏感性的分子生物学机制。方法:体外培养胃癌SGC-7901细胞,通过转染miR-126模拟序列上调细胞内的miR-126水平,使用RT-q PCR及Western blot检测miR-126上调后zeste基因增强子同源物2(EZH2)的mRNA及蛋白水平的变化。双萤光素酶报告基因实验确认miR-126与EZH2的靶向结合关系。在上调miR-126水平的同时,通过共转染pc DNA3.1-EZH2真核表达质粒提高细胞内的EZH2表达,CCK-8法及流式细胞术分析照射后胃癌细胞的活力及凋亡率的变化,从而评估EZH2过表达对miR-126放射增敏作用的影响。结果:上调胃癌SGC-7901细胞中的miR-126水平可以显著抑制EZH2的mRNA及蛋白水平(P<0.05)。双萤光素酶报告基因实验提示miR-126与EZH2的mRNA间存在直接靶向关系。与仅上调miR-126的细胞相比,上调miR-126水平的同时过表达EZH2水平,将导致照射后SGC-7901细胞的活力增加,凋亡率减少(P<0.05)。结论:对EZH2靶向抑制是miR-126增强胃癌SGC-7901细胞放射敏感性的机制之一。
AIM: To investigate the molecular biological mechanisms by which microRNA-126( miR-126) enhances the radiosensitivity of gastric cancer cells. METHODS: SGC-7901 cells were cultured in vitro. In order to over-express miR-126 in SGC-7901 cells,miR-126 mimic was transfected. The mRNA and protein levels of enhancer of zeste homolog 2( EZH2) were detected by RT-q PCR and Western blot,respectively. The targeting relationship between miR-126 and EZH2 was determined by dual-luciferase reporter assay. To estimate the effect of EZH2 on miR-126-enhanced radiosensitivity of the SGC-7901 cells,the pc DNA3. 1-EZH2 vector was also co-transfected with miR-126 mimic,and then CCK-8 assay and flow cytometry were used to detect the viability and apoptotic rate of the cells after radiation. RESULTS: Overexpression of miR-126 significantly inhibited the expression of EZH2 in SGC-7901 cells both at protein and mRNA levels( P〈0. 05). A direct targeting relationship between miR-126 and EZH2 was confirmed by dual-luciferase reporter assay.Compared with the cells only transfected with miR-126 mimic,co-transfection of pc DNA3. 1-EZH2 with miR-126 mimic increased the viability but reduced the apoptosis of the cells treated by radiation( P〈0. 05). CONCLUSION: Targeting inhibition of EZH2 may be one of the mechanisms by which miR-126 enhances the radiosensitivity of gastric cancer cells.
作者
田晓刚
赵林
张春林
任锦霞
赵凤菊
杨文翠
苟彩霞
TIAN Xiao-gang;ZHAO Lin;ZHANG Chun-lin;REN Jin-xia;ZHAO Feng-ju;YANG Wen-cui;GOU Cai-xia(The First Ward of Radiotherapy Department,Gansu Provincial Cancer Hospital,Lanzhou 730050,Chin)
出处
《中国病理生理杂志》
CAS
CSCD
北大核心
2018年第8期1461-1467,共7页
Chinese Journal of Pathophysiology